Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q79671174)
Watch
English
Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?
scientific article published on 01 February 2007
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
editorial
0 references
title
Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
main subject
chronic hepatitis B
1 reference
based on heuristic
inferred from title
chronic hepatitis
1 reference
based on heuristic
inferred from title
author name string
Yun-Fan Liaw
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
language of work or name
English
0 references
publication date
1 February 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
published in
Hepatology
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
volume
45
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
page(s)
266-268
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
cites work
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B: update of recommendations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Virologic response and resistance to adefovir in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evolution of multi-drug resistant hepatitis B virus during sequential therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FHEP.21546
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/HEP.21546
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
PubMed ID
17256763
1 reference
stated in
Europe PubMed Central
PubMed ID
17256763
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17256763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit